📰 Analytical Reference Standards News
Analytical Reference Standards News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Analytical Reference Standards. Real-time updates on events, politics, business and more.
June 12, 2024
Pervasip (OTCMKTS:PVSP – Get Free Report) and ChromaDex (NASDAQ:CDXC – Get Free Report) are both small-cap utilities companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, institutional ownership, earnings and risk. Volatility & Risk Pervasip has a beta of 0.21, […]
April 9, 2024
ChromaDex (NASDAQ:CDXC – Get Free Report) had its price objective hoisted by stock analysts at Roth Mkm from $4.25 to $6.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Roth Mkm’s price objective points to a potential upside of 44.58% […]
April 7, 2024
ChromaDex (NASDAQ:CDXC – Get Free Report) and FitLife Brands (NASDAQ:FTLF – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership. Profitability This table compares ChromaDex and FitLife Brands’ […]
April 4, 2024
ChromaDex Co. (NASDAQ:CDXC – Get Free Report) shares passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $1.66 and traded as high as $3.95. ChromaDex shares last traded at $3.95, with a volume of 346,416 shares traded. Analyst Upgrades and Downgrades […]
February 20, 2024
StockNews.com upgraded shares of ChromaDex (NASDAQ:CDXC – Free Report) from a buy rating to a strong-buy rating in a research note released on Friday morning. ChromaDex Stock Performance CDXC stock opened at $1.62 on Friday. The company’s 50 day moving average is $1.47 and its 200 day moving average is $1.45. The stock has a […]
February 20, 2024
StockNews.com upgraded shares of ChromaDex (NASDAQ:CDXC – Free Report) from a buy rating to a strong-buy rating in a research report report published on Friday morning. ChromaDex Stock Performance Shares of NASDAQ:CDXC opened at $1.62 on Friday. ChromaDex has a 52 week low of $1.25 and a 52 week high of $1.99. The company has […]
February 8, 2024
ChromaDex (NASDAQ:CDXC – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Wednesday. ChromaDex Stock Performance Shares of NASDAQ CDXC traded up $0.02 during mid-day trading on Wednesday, hitting $1.54. The stock had a trading volume […]
February 2, 2024
StockNews.com cut shares of ChromaDex (NASDAQ:CDXC – Free Report) from a strong-buy rating to a buy rating in a research note published on Tuesday. ChromaDex Stock Up 3.4 % NASDAQ CDXC opened at $1.51 on Tuesday. The stock has a market cap of $113.44 million, a P/E ratio of -16.78 and a beta of 1.79. […]
January 10, 2024
StockNews.com upgraded shares of ChromaDex (NASDAQ:CDXC – Free Report) from a buy rating to a strong-buy rating in a report issued on Saturday. ChromaDex Trading Up 2.8 % Shares of CDXC opened at $1.48 on Friday. The company has a market capitalization of $111.18 million, a price-to-earnings ratio of -16.44 and a beta of 1.79. […]
January 2, 2024
StockNews.com upgraded shares of ChromaDex (NASDAQ:CDXC – Free Report) from a buy rating to a strong-buy rating in a report released on Friday. ChromaDex Trading Down 3.4 % ChromaDex stock opened at $1.43 on Friday. The business has a 50-day moving average of $1.41 and a 200-day moving average of $1.49. ChromaDex has a 1 […]